Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Frontiers in Neurology
|
March 27, 2020
The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
Laila Abdullah, Fiona Crawford, Magda Tsolaki, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 27, 2010
Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease
Daniel Paris, Nowel Ganey, Magdalena Banasiak, et al.
Microbial Genomics
|
July 24, 2018
Comparative pan-genomic analyses of Orientia tsutsugamushi reveal an exceptional model of bacterial evolution driving genomic diversity
Amy Fleshman, Kristin Mullins, Jason Sahl, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 21, 2019
α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease
Dylan Shea, Cheng-Chieh Hsu, Timothy M Bi, et al.
Neurotoxicology
|
April 29, 2020
Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model
Utsav Joshi, James E Evans, Andrew Pearson, et al.
Cytokine
|
October 7, 2008
Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease
Ghania Ait-ghezala, Laila Abdullah, Claude-Henry Volmar, et al.
Scientific Reports
|
July 25, 2019
Author Correction: Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
Utsav Joshi, James E Evans, Ross Joseph, et al.
Scientific Reports
|
August 29, 2018
Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
Utsav Joshi, James E Evans, Ross Joseph, et al.
Scientific Reports
|
January 9, 2026
Oleoylethanolamide supplementation improves mood and reduces fatigue in veterans with GWI in a 15-week randomized, double-blind, placebo-controlled exploratory clinical trial
Laila Abdullah, Andrew P Keegan, Michael Hoffmann, et al.
Eclinicalmedicine
|
November 10, 2025
Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial
Aina-Ekisha Kahatano, Maxmillian Mpina, Fiona Vanobberghen, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Frontiers in Neurology
|
March 27, 2020
The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
Laila Abdullah, Fiona Crawford, Magda Tsolaki, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 27, 2010
Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease
Daniel Paris, Nowel Ganey, Magdalena Banasiak, et al.
Microbial Genomics
|
July 24, 2018
Comparative pan-genomic analyses of Orientia tsutsugamushi reveal an exceptional model of bacterial evolution driving genomic diversity
Amy Fleshman, Kristin Mullins, Jason Sahl, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 21, 2019
α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease
Dylan Shea, Cheng-Chieh Hsu, Timothy M Bi, et al.
Neurotoxicology
|
April 29, 2020
Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model
Utsav Joshi, James E Evans, Andrew Pearson, et al.
Cytokine
|
October 7, 2008
Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease
Ghania Ait-ghezala, Laila Abdullah, Claude-Henry Volmar, et al.
Scientific Reports
|
July 25, 2019
Author Correction: Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
Utsav Joshi, James E Evans, Ross Joseph, et al.
Scientific Reports
|
August 29, 2018
Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness
Utsav Joshi, James E Evans, Ross Joseph, et al.
Scientific Reports
|
January 9, 2026
Oleoylethanolamide supplementation improves mood and reduces fatigue in veterans with GWI in a 15-week randomized, double-blind, placebo-controlled exploratory clinical trial
Laila Abdullah, Andrew P Keegan, Michael Hoffmann, et al.
Eclinicalmedicine
|
November 10, 2025
Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial
Aina-Ekisha Kahatano, Maxmillian Mpina, Fiona Vanobberghen, et al.
Page
of 9